These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10082441)

  • 1. Immunomodulatory actions of intravenous immunoglobulin (IVIG): potential applications in solid organ transplant recipients.
    Jordan SC; Tyan D; Czer L; Toyoda M
    Pediatr Transplant; 1998 May; 2(2):92-105. PubMed ID: 10082441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intravenous polyclonal immunoglobulins (IVIG): what use in transplantation?].
    Haymann JP; Glotz D
    Nephrologie; 1999; 20(3):139-43. PubMed ID: 10418003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic strategies in management of the highly HLA-sensitized and ABO-incompatible transplant recipients.
    Jordan SC; Peng A; Vo AA
    Contrib Nephrol; 2009; 162():13-26. PubMed ID: 19001810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ.
    Tyan DB; Li VA; Czer L; Trento A; Jordan SC
    Transplantation; 1994 Feb; 57(4):553-62. PubMed ID: 8116041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantation.
    Jordan SC; Toyoda M; Vo AA
    Expert Rev Clin Immunol; 2011 May; 7(3):341-8. PubMed ID: 21595600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal polyspecific immunoglobulin G (IVIg) in the treatment of autoimmune diseases.
    Hurez V; Kaveri SV; Kazatchkine MD
    J Autoimmun; 1993 Dec; 6(6):675-81. PubMed ID: 8155249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of autoimmune diseases and systemic vasculitis with pooled human intravenous immune globulin.
    Jordan SC; Toyoda M
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):31-8. PubMed ID: 8033432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-transplant therapy with high-dose intravenous gammaglobulin: Applications to treatment of antibody-mediated rejection.
    Jordan SC; Vo AA; Toyoda M; Tyan D; Nast CC
    Pediatr Transplant; 2005 Apr; 9(2):155-61. PubMed ID: 15787786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunomodulatory effects of intravenous immunoglobulins].
    Kazatchkine M; Mouthon L; Kaveri SV
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S13-8. PubMed ID: 10896983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model.
    Blank M; Anafi L; Zandman-Goddard G; Krause I; Goldman S; Shalev E; Cervera R; Font J; Fridkin M; Thiesen HJ; Shoenfeld Y
    Int Immunol; 2007 Jul; 19(7):857-65. PubMed ID: 17576752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous human immunoglobulin treatment of serum from HLA-sensitized patients in kidney transplantation.
    Picascia A; Grimaldi V; Paolillo R; Vasco M; Casamassimi A; De Luca FP; Cavalca F; Schiano C; Napoli C
    Ren Fail; 2014 May; 36(4):585-8. PubMed ID: 24456257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of peritransplant and rescue intravenous immunoglobulin and extracorporeal immunoadsorption in lung transplant recipients sensitized to HLA antigens.
    Appel JZ; Hartwig MG; Davis RD; Reinsmoen NL
    Hum Immunol; 2005 Apr; 66(4):378-86. PubMed ID: 15866701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients.
    Drakos SG; Kfoury AG; Long JW; Stringham JC; Fuller TC; Nelson KE; Campbell BK; Gilbert EM; Renlund DG
    Ann Thorac Surg; 2006 Sep; 82(3):889-93. PubMed ID: 16928502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.
    Jordan SC; Tyan D; Stablein D; McIntosh M; Rose S; Vo A; Toyoda M; Davis C; Shapiro R; Adey D; Milliner D; Graff R; Steiner R; Ciancio G; Sahney S; Light J
    J Am Soc Nephrol; 2004 Dec; 15(12):3256-62. PubMed ID: 15579530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients.
    Jordan SC; Vo A; Bunnapradist S; Toyoda M; Peng A; Puliyanda D; Kamil E; Tyan D
    Transplantation; 2003 Aug; 76(4):631-6. PubMed ID: 12973100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of intravenous polyclonal immunoglobulins in autoimmune and inflammatory disorders].
    Graff-Dubois S; Sibéril S; Elluru S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayary J; Kaveri SV
    Transfus Clin Biol; 2007 May; 14(1):63-8. PubMed ID: 17498995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss.
    Sapir T; Blank M; Shoenfeld Y
    Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IVIG and HLA antibodies. Evidence for inhibition of complement activation but not for anti-idiotypic activity.
    Watanabe J; Scornik JC
    Am J Transplant; 2005 Nov; 5(11):2786-90. PubMed ID: 16212641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulins and transplantation for patients with anti-HLA antibodies.
    Glotz D; Antoine C; Julia P; Pegaz-Fiornet B; Duboust A; Boudjeltia S; Fraoui R; Combes M; Bariety J
    Transpl Int; 2004 Jan; 17(1):1-8. PubMed ID: 14685653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulation with intravenous immunoglobulin.
    Hall PD
    Pharmacotherapy; 1993; 13(6):564-73. PubMed ID: 8302679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.